Oral eltrombopag versus subcutaneous recombinant human thrombopoietin for promoting platelet engraftment after allogeneic stem cell transplantation: A prospective, non‐inferiority, randomized controlled trial
Sign Up to like & getrecommendations! Published in 2022 at "Hematological Oncology"
DOI: 10.1002/hon.3017
Abstract: Delayed platelet engraftment (DPE) is associated with poor survival and increased transplantation‐related mortality after allogeneic hematopoietic stem cell transplantation (allo‐HSCT). Therefore, treatments are needed to improve platelet engraftment and prevent DPE. We performed a phase… read more here.
Keywords: day; platelet engraftment; group; transplantation ... See more keywords
Herombopag promotes platelet engraftment and decreases platelet transfusion after allogeneic hematopoietic stem cell transplantation
Sign Up to like & getrecommendations! Published in 2023 at "European Journal of Haematology"
DOI: 10.1111/ejh.13925
Abstract: The delayed platelet engraftment associated with allogeneic hematopoietic stem cell transplantation (allo‐HSCT) is a common complication and often results in increased transplant‐related complications. A single‐center, prospective, investigator‐initiated pilot study was conducted to explore whether herombopag,… read more here.
Keywords: allogeneic hematopoietic; engraftment; platelet engraftment; range ... See more keywords
A Novel Recombinant Human Thrombopoietin Therapy for Promoting Platelet Engraftment in Haematological Malignancies after Single Umbilical Cord Blood Transplantation: A Prospective Randomized Controlled Trial
Sign Up to like & getrecommendations! Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-199
Abstract: Background: Umbilical cord blood transplantation (UCBT) is an alternative to matched-unrelated or mismatched-related peripheral blood (PB) or BMT and has emerged as a widely accepted treatment for a wide variety of hematologic malignancies. However, delayed… read more here.
Keywords: group; platelet engraftment; haematological malignancies; blood ... See more keywords
A New Prediction System for Platelet Recovery after Autologous Stem Cell Transplantation in B-Cell Non-Hodgkin Lymphomas
Sign Up to like & getrecommendations! Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-112864
Abstract: Transient thrombocytopenia is common after autologous peripheral blood stem cell transplantation (auto-PBSCT). Although patients underwent auto-PBSCT usually show the recovery of peripheral leukocytes and platelets counts within a couple of weeks after auto-PBSCT, delayed platelet… read more here.
Keywords: recovery; cell; platelet engraftment; auto pbsct ... See more keywords
Autologous Peripheral Blood Stem Cell Transplantation Among Lymphoproliferative Disease Patients: Factors Influencing Engraftment
Sign Up to like & getrecommendations! Published in 2019 at "Oman Medical Journal"
DOI: 10.5001/omj.2019.06
Abstract: Objectives Autologous peripheral blood stem cells transplantation (APBSCT) is a therapeutic option which can be used in various hematological, neoplastic disorders including lymphoproliferative disease (LPD). Differences in patient populations and treatment modalities in different transplant… read more here.
Keywords: engraftment; platelet engraftment; disease; transplantation ... See more keywords